Super MRI scans hand damage in rare disease
NCT ID NCT04223817
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study used a very powerful 7 Tesla MRI to look at the hands of 50 people with systemic sclerosis (scleroderma), a rare autoimmune disease. The goal was to see bone, joint, and blood vessel problems in detail. Researchers hope this will help them understand how the disease affects hands.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how doctors detect and understand hand joint and blood vessel damage in systemic sclerosis.
- What could go wrong
- This is a small, completed imaging study, not a treatment trial. The findings may not change current care or apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAGNETIC RESONANCE IMAGING (MRI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Poitiers University Hospital
Poitiers, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can skin biopsies unlock new treatments for scleroderma?
- Could a skin patch ease stomach pain in scleroderma?
- Could a painless microneedle pad ease Raynaud's in scleroderma?
- Can a new pill ease the hardening skin of systemic sclerosis?
- A drug after transplant may stop scleroderma from coming back
- Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.